The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Baum Charles M since 2013.
This trader's CIK number is 1579824.
At the time of last reporting, Baum Charles M was the President,Founder,Head of R&D of Mirati Therapeutics, Inc.. (stock ticker symbol MRTX).
Also see all insider trading activities at Mirati Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | MRTX | 0 | $0 | 84,979 | $8,206,874 | 72,959 | $1,305,727 |
| 2021 | MRTX | 0 | $0 | 51,715 | $7,311,900 | 52,741 | $500,752 |
| 2020 | MRTX | 0 | $0 | 80,000 | $13,080,680 | 89,826 | $778,167 |
| 2019 | MRTX | 0 | $0 | 103,620 | $8,529,531 | 108,119 | $1,186,740 |
| 2018 | MRTX | 0 | $0 | 103,620 | $4,452,499 | 115,106 | $1,080,741 |
| 2016 | MRTX | 20,000 | $141,080 | 0 | $0 | 0 | $0 |
| 2014 | MRTX | 0 | $0 | 0 | $0 | 23,556 | $199,990 |
| 2013 | MRTX | 5,000 | $84,820 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | ARRY | 0 | $0 | 50,000 | $844,999 | 55,000 | $277,000 |
| 2017 | ARRY | 0 | $0 | 25,000 | $231,750 | 30,000 | $149,100 |
| 2016 | ARRY | 0 | $0 | 0 | $0 | 5,000 | $29,150 |
| 2015 | ARRY | 0 | $0 | 25,000 | $184,475 | 25,000 | $96,500 |
1. Mirati Therapeutics, Inc. (MRTX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-12-21 | MRTX | Sale | 9,092 | 40.42 | 367,471 |
| 2022-11-28 | MRTX | Sale | 69,256 | 100.00 | 6,925,600 |
| 2022-11-28 | MRTX | Option Ex | 69,256 | 17.41 | 1,205,746 |
| 2022-01-18 | MRTX | Option Ex | 3,703 | 27.00 | 99,981 |
| 2022-01-18 | MRTX | Sale | 2,517 | 120.48 | 303,253 |
| 2022-01-04 | MRTX | Sale | 4,114 | 148.41 | 610,550 |
| 2021-12-03 | MRTX | Option Ex | 47,204 | 8.49 | 400,761 |
| 2021-12-03 | MRTX | Sale | 47,204 | 134.54 | 6,350,967 |
| 2021-01-26 | MRTX | Option Ex | 2,292 | 5.40 | 12,376 |
| 2021-01-19 | MRTX | Option Ex | 3,245 | 27.00 | 87,615 |
| 2021-01-06 | MRTX | Sale | 4,511 | 213.02 | 960,933 |
| 2020-12-18 | MRTX | Sale | 40,000 | 236.47 | 9,458,880 |
| 2020-12-18 | MRTX | Option Ex | 40,000 | 8.49 | 339,600 |
| 2020-04-27 | MRTX | Option Ex | 557 | 5.40 | 3,007 |
| 2020-04-17 | MRTX | Sale | 40,000 | 90.55 | 3,621,800 |
| 2020-04-17 | MRTX | Option Ex | 40,000 | 8.49 | 339,600 |
| 2020-03-27 | MRTX | Option Ex | 2,291 | 5.40 | 12,371 |
| 2020-02-28 | MRTX | Option Ex | 2,291 | 5.40 | 12,371 |
| 2020-02-04 | MRTX | Option Ex | 4,687 | 15.20 | 71,218 |
| 2019-12-24 | MRTX | Option Ex | 318 | 15.20 | 4,832 |
| 2019-08-22 | MRTX | Option Ex | 52,368 | 12.96 | 678,846 |
| 2019-08-22 | MRTX | Sale | 51,810 | 87.68 | 4,542,804 |
| 2019-02-25 | MRTX | Option Ex | 51,810 | 8.50 | 440,385 |
| 2019-02-25 | MRTX | Sale | 51,810 | 76.95 | 3,986,727 |
| 2019-02-21 | MRTX | Option Ex | 3,623 | 17.30 | 62,677 |
| 2018-08-23 | MRTX | Sale | 51,810 | 57.71 | 2,990,162 |
| 2018-08-24 | MRTX | Option Ex | 11,486 | 17.41 | 199,971 |
| 2018-08-23 | MRTX | Option Ex | 51,810 | 8.50 | 440,385 |
| 2018-02-23 | MRTX | Option Ex | 51,810 | 8.50 | 440,385 |
| 2018-02-23 | MRTX | Sale | 51,810 | 28.23 | 1,462,337 |
| 2016-06-14 | MRTX | Buy | 20,000 | 7.05 | 141,080 |
| 2014-07-25 | MRTX | Option Ex | 11,778 | 8.49 | 99,995 |
| 2014-02-19 | MRTX | Option Ex | 11,778 | 8.49 | 99,995 |
| 2013-11-26 | MRTX | Buy | 5,000 | 16.96 | 84,820 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-10-26 | ARRY | Option Ex | 5,000 | .00 | 0 |
| 2018-02-09 | ARRY | Sale | 50,000 | 16.90 | 844,999 |
| 2018-02-09 | ARRY | Option Ex | 50,000 | 5.54 | 277,000 |
| 2017-10-27 | ARRY | Option Ex | 5,000 | 10.47 | 52,350 |
| 2017-03-28 | ARRY | Option Ex | 25,000 | 3.87 | 96,750 |
| 2017-03-28 | ARRY | Sale | 25,000 | 9.27 | 231,750 |
| 2016-10-29 | ARRY | Option Ex | 5,000 | 5.83 | 29,150 |
| 2015-05-08 | ARRY | Option Ex | 25,000 | 3.86 | 96,500 |
| 2015-05-08 | ARRY | Sale | 25,000 | 7.38 | 184,475 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Baum Charles M (President,Founder,Head of R&D of Mirati Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.